References
- Autier P. Shannoun F, Scharpantgen A, Lux C, Back C, Seven G, et al. A breast cancer screening programme operating in a liberal health care system: the Luxembourg Mammography Programme, 1992-1997. Int J Cancer 2002;97:828–32.
- Blamey RW. The British Association of Surgical Oncology Guidelines for surgeons in the management of symptomatic breast disease in the UK (1998 revision). BASO Breast Specialty Group. Eur J Surg Oncol 1998;24:464–76.
- Blichert-Toft M, Smola MG, Cataliotti L, O'Higgins N. Principles and guidelines for surgeons: management of symptomatic breast cancer. European Society of Surgical Oncology. Eur J Surg Oncol 1997;23:101–9.
- Bulliard JL, De Landtsheer JP, Levi F. Results from the Swiss mammography screening pilot programme. Eur J Cancer 2003;39:1761–9.
- Danish National Board of Health, Evaluation of the Danish National Cancer Action Plan — status and future monitoring. Danish National Board of Health, Copenhagen; 2004 [Danish].
- EUREF, EUREF Certification Protocol. 2001.
- Fracheboud J, de Koning HJ, Boer R, Groenewoud JH, Verbeek AL, Broeders MJ, et al. Nationwide breast cancer screening programme fully implemented in The Netherlands. Breast 2001;10:6–11.
- Giordano L, Giorgi D, Fasolo G, Segnan N, del Turco MR. Breast cancer screening: characteristics and results of the Italian programmes in the Italian group for planning and evaluating breast cancer screening programmes (gisma). Tumori 1996;82:31–7.
- Irwig L, Macaskill P. Houssami N. Evidence relevant to the investigation of breast symptoms: the triple test. Breast 2002;11:215–20.
- Jensen A, Olsen AH, von Euler-Chelpin M, Njor SH, Vejborg I, Lynge E. Do non-attenders in mammography screening programmes seek mammography elsewhere? Int J Cancer 2005;113:464–70.
- Kamphausen BH, Toellner T, Ruschenburg I. The value of ultrasound-guided fine-needle aspiration cytology of the breast: 354 cases with cytohistological correlation. Anticancer Res 2003;23: 3009–13.
- Lynge E, Olsen AH, Fracheboud J, Patnick J. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prey 2003;12:213–22.
- Mammography Screening Evaluation Group HSCHC, Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening EvaluationGroup.APMIS Suppl 1998;83:1–44.
- Njor SH, Olsen AH, Bellstrom T, Dyreborg U, Bak M, Axelsson C, et al. Mammography screening in the county of Fyn. November 1993-December 1999. APMIS Suppl 2003;(110):1–33.
- O'Higgins N, Linos DA, Blichert-Toft M, Cataliotti L, de Wolf C, Rochard F, et al. European guidelines for quality assurance in the surgical management of mammographically detected lesions. Eur J Surg Oncol 1998;24:96–8.
- Paci E, Giorgi D, Bianchi S, Vezzosi V. Zappa M, Crocetti E, et al. Assessment of the early impact of the population-based breast cancer screening programme in Florence (Italy) using mortality and surrogate measures. Eur J Cancer 2002;38:568–73.
- Perry N. Quality assurance in the diagnosis of breast disease. EUSOMA Working Party. Eur J Cancer 2001;37:159–72.
- Perry N, Broeders M, de Wolf C, To-mberg S. European Guidelines for Quality Assurance in Mammography Screening, 3rd ed. Bruxelles: European Commision; 2002.
- Rutgers EJ. Quality control in the locoregional treatment of breast cancer. Eur J Cancer 2001;37: 447–53.
- The requirements of a specialist breast unit. Eur J Cancer 2000;36:2288–93.
- Vizcaino I, Salas D, Vilar JS, Ruiz-Perales F, Herranz C, Ibanez J. Breast cancer screening: first round in the population-based program in Valencia, Spain. Collaborative Group of Readers of the Breast Cancer Screening Program of the Valencia Community. Radiology ;206:253–60.
- Wang H, Karesen R, Hervik A, Thoresen SO. Mammography screening in Norway: results from the first screening round in four counties and cost-effective-ness of a modeled nationwide screening. Cancer Causes Control 2001;12:39–45.
- Available at: www.statistikbanken.dk